A new study evaluated the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicating that they remained at high risk for hospitalization and death.
The research has been published in the ‘Annals of Oncology Journal’.
The study showed that fully vaccinated patients who experienced breakthrough infections had a hospitalization rate of 65 per cent, an ICU or mechanical ventilation rate of 19 per cent, and a 13 per cent death rate. The study was conducted by the COVID-19 and Cancer Consortium (CCC19), a group of 129 research centres that has been tracking the impact of COVID-19 on patients with cancer since the beginning of the pandemic.
“Patients with cancer who develop breakthrough COVID-19 even following full vaccination can still experience severe outcomes, including death,” said Toni Choueiri, MD, director of the Lank Center for Genitourinary Care at Dana-Farber Cancer Institute and a senior author on the report.
“That is why a multilayered approach that includes masking and social-distancing, along with vaccination plus booster against COVID-19 remains an essential approach for the foreseeable future,” he added. (Read more from “Study: Fully Vaccinated COVID-19 Patients With Cancer Had Super-High Mortality Rate” HERE)
Delete Facebook, Delete Twitter, Follow Restoring Liberty and Joe Miller at gab HERE.